News and Trends 13 Jun 2023 ITM follows €255M investment round by opening new facility …Middle East and Africa (EMEA) region and beyond. “Recent events – including COVID – have taught us that if we are to invest in developing radiopharmaceutical products, we must also… June 13, 2023 - 5 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
News and Trends 29 Mar 2018 Cancer Trial Halted in the UK After Overdosing First Patient Redx Pharma has temporarily interrupted recruitment in a Phase I/IIa cancer trial following “significant adverse events” of its drug on the first patient treated. The first time Redx Pharma’s cancer… March 29, 2018 - 2 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
News and Trends 11 Aug 2022 Regen BioPharma develops new approach for boosting CAR-T cell efficiency to treat solid tumors …which prevents this exhaustion. The disclosed technology induces an intracellular program in T cells to endow them with certain features of “younger” cells, thus allowing for enhanced activity against conventional… August 11, 2022 - 2 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
News and Trends 8 Nov 2022 Google and Meta AI could boost cancer research and drug discovery …role that many proteins play in disease, such as cancer, is already known, but the lack of a deep knowledge of their functioning at the molecular level prevents the development… November 8, 2022 - 3 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
News and Trends 14 Dec 2022 OncoHost to launch PROphet for non-small cell lung cancer in the U.S. in 2023 …one thing they can’t afford to lose – time. Not to mention the waste of resources, the frustration due to treatment failure, and unnecessary adverse events. Clinical issue In a… December 14, 2022 - 7 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
In Depth 1 Jul 2024 Special Olympics: How is biotechnology revolutionizing sports performance worldwide? …growing concerns surrounding “gene doping,” which refers to the illegal use of gene therapy by athletes in order to improve their performance in sporting events. One example of a gene… July 1, 2024 - 5 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
News and Trends 24 Jan 2023 First leukemia patient dosed with SMART101 …related adverse events have been reported. Frédéric Lehmann, chief medical officer of Smart Immune, said: “The infusion of the first patient is a significant milestone in our journey to address… January 24, 2023 - 2 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
Interview 12 Feb 2018 MorphoSys’ CEO Tells Us What’s Next for Europe’s Antibody Expert …Moroney told us. This validates the company’s original business plan, which looked to partner exciting drugs with pharma companies to see them over the line. Tremfya prevents IL-23 from interacting… February 12, 2018 - 8 minutesmins - By Alex Dale Share WhatsApp Twitter Linkedin Email
Startup Scout 18 May 2018 This French Biotech Targets Retinal Cells to Treat Blindness …down or even prevents the death of these cells, thereby stopping vision loss. This could be especially helpful for patients with retinitis pigmentosa, a severe form of vision loss that… May 18, 2018 - 2 minutesmins - By Alexander Burik Share WhatsApp Twitter Linkedin Email
Interview 5 Apr 2021 Base Editing: The Next Frontier in Genome Editing Technology …to ten gene-editing events to generate a persistent primary cell capable of surviving in an immunosuppressive tumor microenvironment. Although CRISPR, ZFNs, or TALENs can achieve this number of gene knockouts,… April 5, 2021 - 4 minutesmins - By Larissa Warneck-Silvestrin Share WhatsApp Twitter Linkedin Email
News and Trends 19 Oct 2017 Austrian Researchers Identify Target for Treatment of Multiple Sclerosis …different genes is regulated by the epigenome – chemical modifications that tell the genome how to behave. HDACs help to tightly package DNA, which prevents proteins from accessing the genome… October 19, 2017 - 3 minutesmins - By Alex Dale Share WhatsApp Twitter Linkedin Email
News and Trends 14 Aug 2024 CAR-T drugs and parkinsonism: a cause for concern? …approval, eight out of 285 patients experienced parkinsonism, with five patients having more severe symptoms of the disease. This was following events of drug-related cytokine-release syndrome (CRS) in patients, a… August 14, 2024 - 3 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email